1. Home
  2. KALA vs NTWK Comparison

KALA vs NTWK Comparison

Compare KALA & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • NTWK
  • Stock Information
  • Founded
  • KALA 2009
  • NTWK 1997
  • Country
  • KALA United States
  • NTWK United States
  • Employees
  • KALA 43
  • NTWK N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • NTWK Computer Software: Prepackaged Software
  • Sector
  • KALA Health Care
  • NTWK Technology
  • Exchange
  • KALA Nasdaq
  • NTWK Nasdaq
  • Market Cap
  • KALA 27.3M
  • NTWK 31.1M
  • IPO Year
  • KALA 2017
  • NTWK 1998
  • Fundamental
  • Price
  • KALA $5.92
  • NTWK $2.66
  • Analyst Decision
  • KALA Strong Buy
  • NTWK
  • Analyst Count
  • KALA 2
  • NTWK 0
  • Target Price
  • KALA $15.00
  • NTWK N/A
  • AVG Volume (30 Days)
  • KALA 31.3K
  • NTWK 21.4K
  • Earning Date
  • KALA 11-12-2024
  • NTWK 02-11-2025
  • Dividend Yield
  • KALA N/A
  • NTWK N/A
  • EPS Growth
  • KALA N/A
  • NTWK N/A
  • EPS
  • KALA N/A
  • NTWK 0.06
  • Revenue
  • KALA N/A
  • NTWK $61,749,408.00
  • Revenue This Year
  • KALA N/A
  • NTWK N/A
  • Revenue Next Year
  • KALA N/A
  • NTWK N/A
  • P/E Ratio
  • KALA N/A
  • NTWK $42.31
  • Revenue Growth
  • KALA N/A
  • NTWK 14.50
  • 52 Week Low
  • KALA $4.21
  • NTWK $1.99
  • 52 Week High
  • KALA $9.25
  • NTWK $3.34
  • Technical
  • Relative Strength Index (RSI)
  • KALA 41.69
  • NTWK 39.20
  • Support Level
  • KALA $5.67
  • NTWK $2.65
  • Resistance Level
  • KALA $6.23
  • NTWK $2.78
  • Average True Range (ATR)
  • KALA 0.31
  • NTWK 0.11
  • MACD
  • KALA -0.07
  • NTWK 0.00
  • Stochastic Oscillator
  • KALA 21.55
  • NTWK 33.33

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.

Share on Social Networks: